Atlas Trials

Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions

Clinical trial NCT01209156 · COMPLETED

Trial details

NCT number
NCT01209156
Sponsor
Institute for Neurodegenerative Disorders
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2010-03-01
Primary completion
2013-06-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.